NPARC (Neuropsychopharmacology Application and Research Center) - About

Our knowledge concerning the functions of the brain is still limited even in a world enjoying the era of information and communication. Consequently, Alzheimer's disease, schizophrenia, Parkinson's disease, autism, and other major disorders directly related to brain functions such as depression and substance abuse as well as the psychosocial problems cannot be treated radically with medical agents.

In recent years, in technologically and scientifically advanced countries, more funding has been allocated to research and development projects for the treatment of brain-related disorders. According to some prominent scientist the present century will witness brain researches at the forefront of scientific studies and some important solutions to brain-related disorders will be imminent.In this context, The United States of America which is  unquestionably the best of the world in the field of neuroscience research, has declared  the 21st century as the "century of brain". Scientific researches are of utmost importance in finding the causes of the disorders and improving new drugs for the treatment of them. In order to conduct researches at the standards of universal science, well-equipped labs and well-trained scientists in the field are required.

Üsküdar University is a thematic university focused on brain researches. The University has all the capabilities in which quality scientific researches and projects can be conducted through a multidisciplinary approach. Neuropsychopharmacology is an important and dynamic field of neuroscience which embodies all the research activities for the treatment of disorders associated with the central nervous system and for the development of new and more effective drugs. Psychiatry collaborates with many other independent disciplines especially pharmacology, neurology and psychology and also  biochemistry, molecular biology, genetics and biophysics. Most scientifically advanced countries conduct neuropsychopharmacological researches. Therefore, within Üsküdar University, a thematic university focused on brain, Neuropsychopharmacology Application and Research Center (NPARC) has been founded. NPARC is the very first center in our country aimed to conduct this kind of researches. There are only a couple of others worldwide.


Through Researches: To adopt a mental perception to conduct scientific researches  leading to innovative findings, to produce new and alternative theory and applications questioning the use of present ones which might eventually lead to a Nobel nomination in the field.

Through Education: To instill a scientific thinking and encourage students to take part in scientific projects and to popularize science, to find talented students and involve them in researches. To train highly qualified academics who adopt an exemplary lifestyle and understanding of a scientist.


  1. To attain the scientific information for the diagnosis and treatment of major brain disorders and transferring and converting this information into technological novelties. To serve to this end, to conduct qualified research projects that lead to new findings, new drugs and diagnostic techniques secured by patent.
  2. Conducting significant researches and training scientists having a highly competitive capability worldwide in accordance with ethical principles in the field of Neuropsychopharmacology.
  3. To motivate students at Üsküdar University through approaches to create a scientific research passion, to have keen and talented students to work in laboratories and also to involve them in ongoing projects through which we can pave the way to train qualified scientists.
  4. To collaborate with other universities and scientific research centers at home and abroad to exchange information and ideas, to develop and conduct joint projects on brain researches through a multidisciplinary approach.
  5. To hold meetings, conferences, seminars and to use brochures and media to inform people about new developments and pharmacological treatment of major brain disorders such as Alzheimer's disease, schizophrenia, autism, depression, Parkinson's disease and drug addiction.


  1. Laboratories in which the nervous system can easily be modeled and behavior of the disorder can be analyzed have been established and put into operation. The Laboratory has international scientific and ethical standards for the experimental neuropsychopharmacology studies.
  2. The center himself grows the animals used in experimental studies such as rats and mice in accordance with the international ethical and accreditation rules.
  3. All major brain disorders can be modeled in experimental animals. Efforts to develop new approaches to understand the etiopathogenesis and treat major brain disorders, especially schizophrenia and substance abuse are currently in progress.
  4. Preclinical psychopharmacological screening studies of newly synthesized drugs that find a chance to enter treatment as psychotropic medication can be performed.
  5. Experimental neuropsychopharmacology studies can be converted into more qualified data with the participation and support of the important disciplines such as neuroanatomy, experimental psychology, molecular biology, pharmacogenetics and biochemistry. An opportunity to work in conjunction with the clinics which is considered to be the final phase is also very convenient.
  6. Considering the benefit ratio for the psychotropic drugs, information that the clinician or the patient needs can be quickly and reliably provided for the most effective use of medication.